Drug of Abuse Testing Market Research Report by Component (Analyzers, Consumables, Laboratory Services, and Rapid Testing Devices), by Sample Type (Blood, Hair, Oral Fluids, Sweat, and Urine), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Drug of Abuse Testing Market is expected to grow from USD 1,429.28 Million in 2020 to USD 1,935.49 Million by the end of 2025.
2. The Global Drug of Abuse Testing Market is expected to grow from EUR 1,253.22 Million in 2020 to EUR 1,697.07 Million by the end of 2025.
3. The Global Drug of Abuse Testing Market is expected to grow from GBP 1,114.11 Million in 2020 to GBP 1,508.70 Million by the end of 2025.
4. The Global Drug of Abuse Testing Market is expected to grow from JPY 152,540.74 Million in 2020 to JPY 206,566.29 Million by the end of 2025.
5. The Global Drug of Abuse Testing Market is expected to grow from AUD 2,075.50 Million in 2020 to AUD 2,810.59 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Drug of Abuse Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Component, the Drug of Abuse Testing Market studied across Analyzers, Consumables, Laboratory Services, and Rapid Testing Devices.
Based on Sample Type, the Drug of Abuse Testing Market studied across Blood, Hair, Oral Fluids, Sweat, and Urine.
Based on End User, the Drug of Abuse Testing Market studied across Criminal Justice Systems and Law Enforcement Agencies, Hospitals, Research Laboratories, and Workplace and School.
Based on Geography, the Drug of Abuse Testing Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Drug of Abuse Testing Market including Abbott Laboratories, Bio-Rad Laboratories, Inc., Danaher Corporation, Drgerwerk AG & Co. KGaA, Express Diagnostics International, F. Hoffmann-La Roche Ltd, LabCorp, Quest Diagnostics Incorporated, Siemens AG, and Thermo Fisher Scientific.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Drug of Abuse Testing Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Drug of Abuse Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug of Abuse Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug of Abuse Testing Market?
4. What is the competitive strategic window for opportunities in the Global Drug of Abuse Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Drug of Abuse Testing Market?
6. What are the modes and strategic moves considered suitable for entering the Global Drug of Abuse Testing Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Drug of Abuse Testing Market is expected to grow from USD 1,429.28 Million in 2020 to USD 1,935.49 Million by the end of 2025.
2. The Global Drug of Abuse Testing Market is expected to grow from EUR 1,253.22 Million in 2020 to EUR 1,697.07 Million by the end of 2025.
3. The Global Drug of Abuse Testing Market is expected to grow from GBP 1,114.11 Million in 2020 to GBP 1,508.70 Million by the end of 2025.
4. The Global Drug of Abuse Testing Market is expected to grow from JPY 152,540.74 Million in 2020 to JPY 206,566.29 Million by the end of 2025.
5. The Global Drug of Abuse Testing Market is expected to grow from AUD 2,075.50 Million in 2020 to AUD 2,810.59 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Drug of Abuse Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Component, the Drug of Abuse Testing Market studied across Analyzers, Consumables, Laboratory Services, and Rapid Testing Devices.
Based on Sample Type, the Drug of Abuse Testing Market studied across Blood, Hair, Oral Fluids, Sweat, and Urine.
Based on End User, the Drug of Abuse Testing Market studied across Criminal Justice Systems and Law Enforcement Agencies, Hospitals, Research Laboratories, and Workplace and School.
Based on Geography, the Drug of Abuse Testing Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Drug of Abuse Testing Market including Abbott Laboratories, Bio-Rad Laboratories, Inc., Danaher Corporation, Drgerwerk AG & Co. KGaA, Express Diagnostics International, F. Hoffmann-La Roche Ltd, LabCorp, Quest Diagnostics Incorporated, Siemens AG, and Thermo Fisher Scientific.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Drug of Abuse Testing Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Drug of Abuse Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug of Abuse Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug of Abuse Testing Market?
4. What is the competitive strategic window for opportunities in the Global Drug of Abuse Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Drug of Abuse Testing Market?
6. What are the modes and strategic moves considered suitable for entering the Global Drug of Abuse Testing Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Component Outlook
3.4. Sample Type Outlook
3.5. End User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for drug abuse treatment
5.1.1.2. Stringent law mandating alcohol and drug testing
5.1.1.3. Increasing drug-related mortality rate and government initiative
5.1.2. Restraints
5.1.2.1. Drug testing is recognized as a violation of privacy rights in some countries
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL DRUG OF ABUSE TESTING MARKET, BY COMPONENT
6.1. Introduction
6.2. Analyzers
6.3. Consumables
6.4. Laboratory Services
6.5. Rapid Testing Devices
7. GLOBAL DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE
7.1. Introduction
7.2. Blood
7.3. Hair
7.4. Oral Fluids
7.5. Sweat
7.6. Urine
8. GLOBAL DRUG OF ABUSE TESTING MARKET, BY END USER
8.1. Introduction
8.2. Criminal Justice Systems and Law Enforcement Agencies
8.3. Hospitals
8.4. Research Laboratories
8.5. Workplace and School
9. AMERICAS DRUG OF ABUSE TESTING MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Abbott Laboratories
13.2. Bio-Rad Laboratories, Inc.
13.3. Danaher Corporation
13.4. Drgerwerk AG & Co. KGaA
13.5. Express Diagnostics International
13.6. F. Hoffmann-La Roche Ltd
13.7. LabCorp
13.8. Quest Diagnostics Incorporated
13.9. Siemens AG
13.10. Thermo Fisher Scientific
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Component Outlook
3.4. Sample Type Outlook
3.5. End User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for drug abuse treatment
5.1.1.2. Stringent law mandating alcohol and drug testing
5.1.1.3. Increasing drug-related mortality rate and government initiative
5.1.2. Restraints
5.1.2.1. Drug testing is recognized as a violation of privacy rights in some countries
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL DRUG OF ABUSE TESTING MARKET, BY COMPONENT
6.1. Introduction
6.2. Analyzers
6.3. Consumables
6.4. Laboratory Services
6.5. Rapid Testing Devices
7. GLOBAL DRUG OF ABUSE TESTING MARKET, BY SAMPLE TYPE
7.1. Introduction
7.2. Blood
7.3. Hair
7.4. Oral Fluids
7.5. Sweat
7.6. Urine
8. GLOBAL DRUG OF ABUSE TESTING MARKET, BY END USER
8.1. Introduction
8.2. Criminal Justice Systems and Law Enforcement Agencies
8.3. Hospitals
8.4. Research Laboratories
8.5. Workplace and School
9. AMERICAS DRUG OF ABUSE TESTING MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Abbott Laboratories
13.2. Bio-Rad Laboratories, Inc.
13.3. Danaher Corporation
13.4. Drgerwerk AG & Co. KGaA
13.5. Express Diagnostics International
13.6. F. Hoffmann-La Roche Ltd
13.7. LabCorp
13.8. Quest Diagnostics Incorporated
13.9. Siemens AG
13.10. Thermo Fisher Scientific
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ANALYZERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CONSUMABLES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LABORATORY SERVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY RAPID TESTING DEVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY BLOOD, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY WORKPLACE AND SCHOOL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. GLOBAL DRUG OF ABUSE TESTING MARKET: SCORES
TABLE 108. GLOBAL DRUG OF ABUSE TESTING MARKET: BUSINESS STRATEGY
TABLE 109. GLOBAL DRUG OF ABUSE TESTING MARKET: PRODUCT SATISFACTION
TABLE 110. GLOBAL DRUG OF ABUSE TESTING MARKET: RANKING
TABLE 111. GLOBAL DRUG OF ABUSE TESTING MARKET: MERGER & ACQUISITION
TABLE 112. GLOBAL DRUG OF ABUSE TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 113. GLOBAL DRUG OF ABUSE TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 114. GLOBAL DRUG OF ABUSE TESTING MARKET: INVESTMENT & FUNDING
TABLE 115. GLOBAL DRUG OF ABUSE TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 116. GLOBAL DRUG OF ABUSE TESTING MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ANALYZERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CONSUMABLES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LABORATORY SERVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY RAPID TESTING DEVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY BLOOD, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY WORKPLACE AND SCHOOL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. GLOBAL DRUG OF ABUSE TESTING MARKET: SCORES
TABLE 108. GLOBAL DRUG OF ABUSE TESTING MARKET: BUSINESS STRATEGY
TABLE 109. GLOBAL DRUG OF ABUSE TESTING MARKET: PRODUCT SATISFACTION
TABLE 110. GLOBAL DRUG OF ABUSE TESTING MARKET: RANKING
TABLE 111. GLOBAL DRUG OF ABUSE TESTING MARKET: MERGER & ACQUISITION
TABLE 112. GLOBAL DRUG OF ABUSE TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 113. GLOBAL DRUG OF ABUSE TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 114. GLOBAL DRUG OF ABUSE TESTING MARKET: INVESTMENT & FUNDING
TABLE 115. GLOBAL DRUG OF ABUSE TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 116. GLOBAL DRUG OF ABUSE TESTING MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL DRUG OF ABUSE TESTING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL DRUG OF ABUSE TESTING MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2020 (USD MILLION)
FIGURE 5. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 7. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL DRUG OF ABUSE TESTING MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL DRUG OF ABUSE TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2020 VS 2025 (%)
FIGURE 15. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2025
FIGURE 17. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ANALYZERS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CONSUMABLES, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LABORATORY SERVICES, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2020 VS 2025 (%)
FIGURE 22. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025
FIGURE 24. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY BLOOD, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUIDS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 30. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025
FIGURE 32. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITALS, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY WORKPLACE AND SCHOOL, 2020 VS 2025 (USD MILLION)
FIGURE 36. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 37. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 39. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 45. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 47. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 58. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 59. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. GLOBAL DRUG OF ABUSE TESTING MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 71. GLOBAL DRUG OF ABUSE TESTING MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 72. GLOBAL DRUG OF ABUSE TESTING MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 73. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL DRUG OF ABUSE TESTING MARKET, BY TYPE
FIGURE 1. GLOBAL DRUG OF ABUSE TESTING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL DRUG OF ABUSE TESTING MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2020 (USD MILLION)
FIGURE 5. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 7. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL DRUG OF ABUSE TESTING MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL DRUG OF ABUSE TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2020 VS 2025 (%)
FIGURE 15. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2025
FIGURE 17. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ANALYZERS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CONSUMABLES, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LABORATORY SERVICES, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2020 VS 2025 (%)
FIGURE 22. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025
FIGURE 24. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY BLOOD, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUIDS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 30. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025
FIGURE 32. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITALS, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY WORKPLACE AND SCHOOL, 2020 VS 2025 (USD MILLION)
FIGURE 36. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 37. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 39. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 45. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 47. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 58. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 59. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. GLOBAL DRUG OF ABUSE TESTING MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 71. GLOBAL DRUG OF ABUSE TESTING MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 72. GLOBAL DRUG OF ABUSE TESTING MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 73. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL DRUG OF ABUSE TESTING MARKET, BY TYPE
